HSBC Holdings’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
PA
ACM
CM
CFM
CA
HSBC Holdings's NAUT Position: Q2 2026 in Review
HSBC Holdings held its Nautilus Biotechnolgy (NAUT) position steady in Q2 2026 at 49,449 shares worth $91.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2815.
HSBC Holdings first reported a position in NAUT in Q4 2021 and has held it in 19 quarters since. The position peaked at $190K in Q1 2026. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.
- HSBC Holdings held 49,449 shares of Nautilus Biotechnolgy worth $91.2K as of Q2 2026.
- HSBC Holdings left its Nautilus Biotechnolgy share count unchanged in Q2 2026.
- Nautilus Biotechnolgy made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2815 holding.
- HSBC Holdings first reported a position in Nautilus Biotechnolgy in Q4 2021 and has held it in 19 quarters since.
- HSBC Holdings's Nautilus Biotechnolgy position peaked at $190K in Q1 2026.
- 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.